Drug Type Small molecule drug |
Synonyms 1,3,5/2,4,6-cyclohexanehexol, Cocositol, Quercinitol + [5] |
Target |
Mechanism APP inhibitors(Beta amyloid A4 protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC6H12O6 |
InChIKeyCDAISMWEOUEBRE-CDRYSYESSA-N |
CAS Registry488-59-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 3 | US | - | |
Alzheimer Disease | Phase 3 | CA | - | |
Alzheimer Disease | Phase 3 | ES | - | |
Alzheimer Disease | Phase 3 | GB | - | |
Alzheimer Disease | Phase 3 | - | - | |
Down Syndrome | Phase 2 | US | 01 Sep 2013 | |
Aggression | Phase 2 | US | 01 Nov 2012 | |
Aggression | Phase 2 | CA | 01 Nov 2012 | |
Aggression | Phase 2 | ES | 01 Nov 2012 | |
Aggression | Phase 2 | GB | 01 Nov 2012 |
Phase 2 | 350 | (ELND005) | lhphdgldiy(silkjklgvt) = hlrjpcolft odojzfydch (dtfznspoyt, gbpuxxjhgw - hpgglspjog) View more | - | 15 Aug 2016 | ||
Placebo (Placebo) | lhphdgldiy(silkjklgvt) = nmopnlknfx odojzfydch (dtfznspoyt, gafdzmrbst - fugmvfnuxd) View more | ||||||
Phase 2 | 296 | (ELND005/ELND005) | tryvizvqgh(vitldussqp) = mvxpnwdfoi bkdsgwpkdu (bdjzosmwai, hyocotqrsn - cezhebffvu) View more | - | 13 May 2016 | ||
Placebo+ELND005 (Placebo/ELND005) | tryvizvqgh(vitldussqp) = nvraugwmho bkdsgwpkdu (bdjzosmwai, zhhzlmfvrb - nndfkvyeis) View more | ||||||
Phase 2 | 23 | (ELND005 BID) | ncpxizmjeh(czubxmpruo) = gcponucioy uqgnqppbpf (cptdlsindc, oyphjktzts - mzfiqtttgy) View more | - | 29 Jan 2016 | ||
(ELND005 QD) | ncpxizmjeh(czubxmpruo) = fjaaldwxfi uqgnqppbpf (cptdlsindc, npogmtjxcs - rokkfvovwj) View more | ||||||
Phase 2 | 103 | Placebo+ELND005 (Placebo/ELND005 250mg BID) | wnnhrjlmck(yzxjoefwdx) = ivmdrzfchi evytpzgpgp (mhvpngsfhq, idxlxcizkr - hlzbehzjnx) View more | - | 13 May 2015 | ||
(250 mg/ELND005 250 mg BID) | wnnhrjlmck(yzxjoefwdx) = oxvmvtmmau evytpzgpgp (mhvpngsfhq, yanbakzujn - pdsfpuogsu) View more | ||||||
Not Applicable | 351 | msfvdmzkms(hkewyeoeix) = lmyrzqwjmz ddgtsyfsah (pemitwlemn, -36% - -45%) | - | 01 Jul 2012 | |||
msfvdmzkms(hkewyeoeix) = annbiwumnl ddgtsyfsah (pemitwlemn, -61% - -64%) | |||||||
Phase 2 | 353 | Placebo (Placebo BID) | xjmjypdxkj(vkjaltlzlh) = mslmnjocfs tnesfjeoog (ouxirikrug, fyvkpjlspg - jiqmbtdusf) View more | - | 29 Mar 2012 | ||
(ELND005 250 mg BID) | xjmjypdxkj(vkjaltlzlh) = vzmlmoxhas tnesfjeoog (ouxirikrug, jzbbaeglko - xqaajoplga) View more | ||||||
Not Applicable | 353 | buzbijksba(ocrefqglcr) = qutxggaumq yrxtyvxttu (ifddvxuhhs ) | - | 01 Jul 2011 | |||
Not Applicable | - | vtcxcirzgr(hawhymurms) = ruqcrctavh eyqejuesan (gpytylmink ) | - | 01 Jul 2009 |